Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Autores principales: Chen, Yaocheng, Cai, Ning, Lai, Yongrong, Xu, Weiwei, Li, Jinyan, Huang, Lan, Huang, Ying, Hu, Meiling, Yang, Huangju, Chen, Jiangming
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394185/
https://ncbi.nlm.nih.gov/pubmed/32792958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01137
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares